As of the latest Form 4 filed Feb 19, 2026.
What Immunocore Holdings Ltd insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 16 most recent filings for IMCR.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-18 | St Leger Tina Amber CHIEF HR OFFICER | SSale | −1.00K | $32.35 | $32.4K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Berman David M HEAD OF R&D | SSale | −5.96K | $32.35 | $193K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | GOLL JOHN SVP, FINANCE & CAO | SSale | −698.00 | $32.35 | $22.6K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-18 | Jallal Bahija CHIEF EXECUTIVE OFFICER | SSale | −11.5K | $32.35 | $371K | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | St Leger Tina Amber CHIEF HR OFFICER | MExercise | +2.12K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | Berman David M HEAD OF R&D | MExercise | +11.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | GOLL JOHN SVP, FINANCE & CAO | MExercise | +1.35K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-19 | 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | MExercise | +23.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-08 | 2025-12-05 | Berman David M HEAD OF R&D | SSale | −572.00 | $40.14 | $23.0K | Yes (planned) | Form 4 ↗ |
| 2025-12-08 | 2025-12-05 | Berman David M, HEAD OF R&D | MExercise | +572.00 | $17.46 | $9.99K | Yes (planned) | Form 4 ↗ |
| 2025-12-08 | 2025-12-04 | Berman David M, HEAD OF R&D | SSale | −31.3K | $40.26 | $1.26M | Yes (planned) | Form 4 ↗ |
| 2025-12-08 | 2025-12-04 | Berman David M, HEAD OF R&D | MExercise | +31.3K | $17.46 | $547K | Yes (planned) | Form 4 ↗ |
| 2025-12-01 | 2025-11-28 | Berman David M HEAD OF R&D | SSale | −5.52K | $40.09 | $221K | Yes (planned) | Form 4 ↗ |
| 2025-12-01 | 2025-11-28 | Berman David M, HEAD OF R&D | MExercise | +5.52K | $17.46 | $96.4K | Yes (planned) | Form 4 ↗ |
| 2025-12-01 | 2025-11-26 | Berman David M, HEAD OF R&D | SSale | −69.4K | $40.12 | $2.78M | Yes (planned) | Form 4 ↗ |
| 2025-12-01 | 2025-11-26 | Berman David M, HEAD OF R&D | MExercise | +69.4K | $17.46 | $1.21M | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also IMCR’s full analysis or the market-wide insider trading feed. The tabs above jump to IMCR’s other SEC data.
Source: SEC Form 4 filings for IMCR, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.